Previous Page  13 / 17 Next Page
Information
Show Menu
Previous Page 13 / 17 Next Page
Page Background

Page 59

allied

academies

J Clin Exp Tox 2017 | Volume 1 | Issue 2

Toxicology and Pharmacology

November 01-02, 2017 | Toronto, Canada

International Conference on

Objective:

To investigate the effect of Yi Shen Pin Gan Fang-a

Chinese Herb Formula in treating the Ultra High Risk for

Psychosis population compared with aripiprazole.

Method:

54 Ultra High Risk for Psychosis population,

matched for age, gender, handedness and education, were

randomly assigned to receive either Yi Shen Pin Gan Fang and

aripiprazole placebo or aripiprazole (5–10 mg/day) and Yi

Shen Pin Gan Fang placebo for a 12-week period. At baseline,

4

th

week, 8

th

week, 12

th

week, clinical effect was evaluated

with the Structured Interview for Prodromal Syndromes

(SIPS), Positive and Negative Syndrome Scale (PANSS) and

the Global Assessment of Functioning Scale (GAF), side effect

was measured by Udvalg for Kliniske Undersogelser (UKU).

Neurocognitive function was assessed at baseline and 12

th

week.

Result:

For GAF, PANSS and SIPS, there was no difference

between two groups (F=0.04, 0.05, 0.15, P>0.05), there was

significant improvement since 4

th

week till 12

th

week in each

group compared with baseline (F=27.16 59.91, 55.92, 0.05,

0.15, P<0.001). Compared with baseline, for the Trail Making

test, there is no difference between and intra groups (P>0.05);

In Chinese Medicine Treatment group, Verbal Learning test,

Visual Memory test, CPT and Stroop-(colour/word) test were

significant improved (P<0.05); For Aripiprazole Treatment

group, only Verbal Learning test, Stroop-word test were

significant improved (P<0.05). No obvious side effects were

found in Yi Shen Pin Gan Fang treatment group.

Conclusion:

Yi Shen Pin Gan Fang was effective in treating

Ultra High Risk for Psychosis population.

e:

jhxlj@vip.163.com

Yi Shen Pin Gan Fang-a Chinese herb formula is effective in treating the ultra-high risk for psychosis

population

Jia Hong-Xiao, Feng Xiujie, Zhu Hong and Liu Shan-Shan

Capital Medical University, China